MetLife Benefits, Losses and Expenses decreased by 22.6% to $17.57B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.0%, from $17.22B to $17.57B. Over 4 years (FY 2021 to FY 2025), Benefits, Losses and Expenses shows an upward trend with a 3.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase often reflects higher claim frequency or severity, which can negatively impact underwriting margins.
This captures the total outflows related to policyholder benefits, claims, and other associated insurance expenses. It r...
This is a fundamental metric for insurance companies; peers are compared based on their loss ratios to determine underwriting discipline.
other_benefits_losses_and_expenses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.04B | $14.86B | $18.78B | $15.04B | $15.56B | $21.85B | $13.58B | $15.13B | $16.19B | $15.33B | $18.09B | $15.01B | $16.62B | $16.45B | $17.29B | $17.22B | $16.36B | $16.15B | $22.70B | $17.57B |
| QoQ Change | — | +5.9% | +26.4% | -19.9% | +3.4% | +40.4% | -37.8% | +11.4% | +7.0% | -5.3% | +18.0% | -17.0% | +10.7% | -1.1% | +5.1% | -0.4% | -5.0% | -1.3% | +40.5% | -22.6% |
| YoY Change | — | — | — | — | +10.8% | +47.0% | -27.7% | +0.6% | +4.1% | -29.8% | +33.2% | -0.8% | +2.6% | +7.3% | -4.4% | +14.7% | -1.6% | -1.8% | +31.3% | +2.0% |
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Group Benefits | — | — | — | — | $5.75B | $6.29B | $5.85B | $5.99B |
| Asia | $2.29B | $2.27B | $2.17B | $2.36B | $2.29B | $2.27B | $2.21B | $2.41B |
| Latin America | $1.34B | $1.45B | $1.52B | $1.57B | $1.70B | $1.55B | $1.59B | $1.62B |
| MetLife Holdings | $1.96B | $1.89B | $1.85B | $1.80B | $1.75B | $1.66B | $1.65B | $1.55B |
| EMEA | $524.00M | $550.00M | $537.00M | $527.00M | $586.00M | $571.00M | $577.00M | $616.00M |
| Corporate & Other | — | — | — | — | — | — | $441.00M | $411.00M |
| Corporate and Other | $450.00M | $440.00M | $485.00M | $511.00M | $539.00M | $454.00M | — | — |
| U.S. | $7.73B | $7.93B | $10.11B | $9.44B | — | — | — | — |
| Total | $13.58B | $15.13B | $16.19B | $15.33B | $18.09B | $15.01B | $16.62B | $16.45B |
Asia, Corporate & Other, Corporate and Other, EMEA, Group Benefits, Latin America, MetLife Holdings, U.S. were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.